ATCC Number:PCS-500-010
細胞形態(tài):其他
生長狀態(tài):貼壁生長
年限:Neonatal
運輸方式:凍存運輸
數(shù)量:大量
是否是腫瘤細胞:0
物種來源:人
規(guī)格:0.1ml Name: Umbilical Cord-Derived Mesenchymal Stem Cells; Normal, Human
Biosafety Level:1
Shipped: frozen
Organism: Homo sapiens (human)
Source: Umbilical cord matrix (Wharton's Jelly)
Growth Properties: Adherent
Age: Neonatal
Morphology: Spindle-shaped, fibroblast-like
Volume per Vial: 1 ml
Ethnicity: Lot-specific
Gender: Lot-specific
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Related Products:Mesenchymal Stem Cell Basal Medium (ATCC PCS-500-030 )
Mesenchymal Stem Cell Growth Kit - Low Serum (ATCC PCS-500-040 )
Dulbecco's Phosphate Buffered Saline (D-PBS) (ATCC 30-2200 )
Trypsin-EDTA for Primary Cells (ATCC PCS-999-003 )
Trypsin Neutralizing Solution (ATCC PCS-999-004 )
Gentamicin-Amphotericin B Solution (ATCC PCS-999-025 )
Penicillin-Streptomycin-Amphotericin B Solution (ATCC PCS-999-002 )
Phenol Red (ATCC PCS-999-001 )
Differentiation Tools
Chondrocyte Differentiation Tool (ATCC PCS-500-051 )
Osteocyte Differentiation Tool (ATCC PCS-500-052 )
Recomended Culture Conditions:See Product Information Sheet Comments:The cells are cryopreserved in the second passage to ensure the highest viability and plating efficiency.
Mesenchymal Stem Cell Basal Medium, when supplemented with Mesenchymal Stem Cell Growth Kit - Low serum components, provides an ideal cell system to propagate mesenchymal stem cells in low serum (2% FBS) conditions. When maintained under optimal growth conditions, ATCC ?Normal Human Umbicial Cord-Derived Mesenchymal Stem Cells have been shown to be multipotent, capable of differentiating down the adipogenic, osteogenic and chondrogenic lineages.
Applications:Adult stem cell differentiation, regenerative medicine, cell therapy, tissue engineering, creation of iPS cell lines
Viability:≥ 50%
Population Doubling Capacity:≥ 10 in complete growth medium and support differentiation
Sterility Tests: Bacteria and Yeast: Negative
Mycoplasma: Negative
Testing: Hepatitis B: Negative
Hepatitis C: Negative
HIV-1, HIV-2: Negative